NO20031754L - Fremgangsmåte for fremstilling av mesylater av piperzinderivater - Google Patents

Fremgangsmåte for fremstilling av mesylater av piperzinderivater

Info

Publication number
NO20031754L
NO20031754L NO20031754A NO20031754A NO20031754L NO 20031754 L NO20031754 L NO 20031754L NO 20031754 A NO20031754 A NO 20031754A NO 20031754 A NO20031754 A NO 20031754A NO 20031754 L NO20031754 L NO 20031754L
Authority
NO
Norway
Prior art keywords
mesylates
preparation
piperazine derivatives
piperazine
derivatives
Prior art date
Application number
NO20031754A
Other languages
English (en)
Other versions
NO20031754D0 (no
NO324460B1 (no
Inventor
Marcel P M Van Aar
Stefanus J Schouten
Jan Zorgdrager
Michiel C Heslinga
Original Assignee
Solvay Pharm Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharm Bv filed Critical Solvay Pharm Bv
Publication of NO20031754L publication Critical patent/NO20031754L/no
Publication of NO20031754D0 publication Critical patent/NO20031754D0/no
Publication of NO324460B1 publication Critical patent/NO324460B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/58Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20031754A 2001-02-16 2003-04-15 Fremgangsmate for fremstilling av mesylater av piperazinderivater NO324460B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01200534 2001-02-16
PCT/EP2002/001666 WO2002066449A2 (en) 2001-02-16 2002-02-14 Process for the preparation of mesylates of piperazine derivatives

Publications (3)

Publication Number Publication Date
NO20031754L true NO20031754L (no) 2003-04-15
NO20031754D0 NO20031754D0 (no) 2003-04-15
NO324460B1 NO324460B1 (no) 2007-10-22

Family

ID=8179894

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20031754A NO324460B1 (no) 2001-02-16 2003-04-15 Fremgangsmate for fremstilling av mesylater av piperazinderivater

Country Status (35)

Country Link
US (1) US7030241B2 (no)
EP (1) EP1362040B1 (no)
JP (1) JP4328528B2 (no)
KR (2) KR101000733B1 (no)
CN (1) CN1176079C (no)
AR (1) AR034206A1 (no)
AT (1) ATE284875T1 (no)
AU (1) AU2002250962B2 (no)
BG (1) BG66101B1 (no)
BR (1) BR0205683A (no)
CA (1) CA2422703C (no)
CZ (1) CZ301780B6 (no)
DE (1) DE60202261T2 (no)
DK (1) DK1362040T3 (no)
DZ (1) DZ3489A1 (no)
ES (1) ES2230481T3 (no)
HK (1) HK1059934A1 (no)
HR (1) HRP20030610B1 (no)
HU (1) HUP0400772A3 (no)
IL (1) IL153509A (no)
IS (1) IS2417B (no)
ME (1) MEP37508A (no)
MX (1) MXPA03002359A (no)
MY (1) MY130687A (no)
NO (1) NO324460B1 (no)
NZ (1) NZ524632A (no)
PL (1) PL208363B1 (no)
PT (1) PT1362040E (no)
RS (1) RS51126B (no)
RU (1) RU2272036C2 (no)
SI (1) SI1362040T1 (no)
SK (1) SK286143B6 (no)
UA (1) UA75390C2 (no)
WO (1) WO2002066449A2 (no)
ZA (1) ZA200301590B (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7435738B2 (en) 2003-08-18 2008-10-14 Solvay Pharmaceuticals, Inc. Stable crystalline form of bifeprunox mesylate (7-[4-([1,1′-biphenyl]-3-ylmethyl)-1-piperazinyl]-2(3H)-benzoxazolone monomethanesulfonate)
AR045362A1 (es) * 2003-08-18 2005-10-26 Solvay Pharm Bv Forma cristalina estable de mesilato de bifeprunox (monometansulfonato de 7-[4-([1,1- bifenil] -3- ilmetil) -1- piperazinil] - 2-(3h) -benzoxazolona
US7405216B2 (en) * 2004-08-18 2008-07-29 Solvay Pharmaceuticals, B.V. Stable crystalline form of bifeprunox mesylate (7-[4-([1,1′-biphenyl]-3-ylmethyl)-1-piperazinyl]-2(3H)-benzoxazolone monomethanesulfonate)
US7423040B2 (en) * 2005-02-18 2008-09-09 Irene Eijgendaal Stable crystalline form of bifeprunox mesylate, dosage forms thereof and methods for using same
US7964604B2 (en) * 2005-02-18 2011-06-21 Solvay Pharmaceuticals B.V. Bifeprunox mesylate maintenance dose compositions and methods for using the same
US20070275977A1 (en) * 2006-05-02 2007-11-29 Van Aar Marcel P N-oxides of pyridylmethyl -piperazine and -piperidine derivatives
US7786126B2 (en) * 2006-06-16 2010-08-31 Solvay Pharmaceuticals B.V. Combination preparations comprising SLV308 and a dopamine agonist
US8106056B2 (en) * 2006-06-16 2012-01-31 Solvay Pharmaceuticals B.V. Combination preparations comprising bifeprunox and a dopamine agonist
US20090068290A1 (en) * 2006-08-31 2009-03-12 Michel Bourin Bifeprunox doses for treating schizophrenia
US20080132520A1 (en) * 2006-08-31 2008-06-05 Winsemius Antje A Compositions, kits and methods for administering a titration schedule comprising bifeprunox compounds
AU2007291234A1 (en) 2006-08-31 2008-03-06 Solvay Pharmaceuticals B.V. Titration schedule for bifeprunox for treating schizophrenia and kits for use therein
EP2249838A4 (en) 2008-02-05 2012-05-02 Harbor Biosciences Inc PHARMACEUTICAL FORMS IN SOLID STATE
WO2011023796A1 (en) 2009-08-31 2011-03-03 Abbott Healthcare Products B.V. Bifeprunox for treating addiction
UY32934A (es) 2009-10-12 2011-05-31 Abbott Healthcare Products Bv Monohidrato de pardoprunox

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3586794T2 (de) * 1984-12-21 1993-05-27 Duphar Int Res Arzneimittel mit psychotroper wirkung.
EP0185429A1 (en) * 1984-12-21 1986-06-25 Duphar International Research B.V New bicyclic heteroaryl piperazines
JPH0344383A (ja) * 1989-07-12 1991-02-26 Ihara Chem Ind Co Ltd 5―トリフルオロメチル―2―ハロメチルベンゾチアゾール類の製造法
JP3044383B2 (ja) * 1990-05-22 2000-05-22 コニカ株式会社 含窒素6員環化合物の製造方法
PT889889E (pt) 1996-03-29 2007-01-31 Duphar Int Res Composto de piperazina e piperidina
SE9702799D0 (sv) 1997-07-25 1997-07-25 Astra Ab New compounds
UA71590C2 (en) 1998-11-13 2004-12-15 Duphar Int Res Piperazine and piperidine derivatives
US7435738B2 (en) * 2003-08-18 2008-10-14 Solvay Pharmaceuticals, Inc. Stable crystalline form of bifeprunox mesylate (7-[4-([1,1′-biphenyl]-3-ylmethyl)-1-piperazinyl]-2(3H)-benzoxazolone monomethanesulfonate)

Also Published As

Publication number Publication date
CN1176079C (zh) 2004-11-17
JP4328528B2 (ja) 2009-09-09
SI1362040T1 (en) 2005-06-30
PL369330A1 (en) 2005-04-18
RS51126B (sr) 2010-10-31
HRP20030610A2 (en) 2005-06-30
KR20030077523A (ko) 2003-10-01
BR0205683A (pt) 2004-07-06
US20040077631A1 (en) 2004-04-22
EP1362040B1 (en) 2004-12-15
IL153509A0 (en) 2003-07-06
ATE284875T1 (de) 2005-01-15
HRP20030610B1 (en) 2006-02-28
BG108090A (bg) 2004-12-30
EP1362040A2 (en) 2003-11-19
CN1463268A (zh) 2003-12-24
SK3092003A3 (en) 2003-09-11
PT1362040E (pt) 2005-05-31
KR101000733B1 (ko) 2010-12-14
ES2230481T3 (es) 2005-05-01
UA75390C2 (en) 2006-04-17
CZ2003697A3 (cs) 2003-06-18
HK1059934A1 (en) 2004-07-23
MY130687A (en) 2007-07-31
PL208363B1 (pl) 2011-04-29
DK1362040T3 (da) 2005-01-24
IL153509A (en) 2007-12-03
NO20031754D0 (no) 2003-04-15
SK286143B6 (sk) 2008-04-07
HUP0400772A2 (hu) 2004-08-30
CA2422703C (en) 2010-04-13
AU2002250962B2 (en) 2006-08-24
RU2272036C2 (ru) 2006-03-20
IS6876A (is) 2003-07-17
NO324460B1 (no) 2007-10-22
ZA200301590B (en) 2004-02-05
US7030241B2 (en) 2006-04-18
MXPA03002359A (es) 2003-06-30
HUP0400772A3 (en) 2008-02-28
WO2002066449A3 (en) 2002-10-24
DE60202261T2 (de) 2005-05-19
WO2002066449A2 (en) 2002-08-29
DE60202261D1 (de) 2005-01-20
CZ301780B6 (cs) 2010-06-23
CA2422703A1 (en) 2002-08-29
IS2417B (is) 2008-10-15
DZ3489A1 (fr) 2002-08-29
MEP37508A (en) 2011-02-10
BG66101B1 (bg) 2011-04-29
AR034206A1 (es) 2004-02-04
YU64403A (sh) 2006-05-25
NZ524632A (en) 2004-03-26
KR100859106B1 (ko) 2008-09-18
JP2004518741A (ja) 2004-06-24
KR20080064206A (ko) 2008-07-08

Similar Documents

Publication Publication Date Title
NO20030012L (no) Fremgangsmåte for fremstilling av substituerte oktanoylamider
NO20042680L (no) Fremgangsmater for fremstilling av O-demetylvenflaxine
NO20040278L (no) Fremgangsmate for fremstilling av perindopril
NO20031754D0 (no) Fremgangsmåte for fremstilling av mesylater av piperzinderivater
IL160043A0 (en) Process for the preparation of indole derivatives
FI20011889A (fi) Menetelmä ksylitolin valmistamiseksi
HUP0401600A3 (en) Process for the preparation of 14-hydroxymorphine derivatives
NO20044814L (no) Fremgangsmate for fremstilling av combretastaniner
NO20042640L (no) Fremgangsmate for fremstilling av ekinocandinderivater
NO20031413D0 (no) Ny fremgangsmåte for fremstilling av oksabispidiner
IL159304A0 (en) Process for the production of piperidine derivatives
NO20035586L (no) Fremgangsmate for fremstilling av cykloheksanol-derivater
IL158360A0 (en) Process for the preparation of 7-substituted 3-alkyl-3h-isobenzofuran-1-one derivatives
HUP0101875A3 (en) Process for the preparation of piperidine derivatives
IL165137A0 (en) Process for the preparation of thioalkylamine derivatives
NO20020059D0 (no) Fremgangsmåte for fremstilling av dibenzotiazepinderivater
NO20030515L (no) Fremgangsmåte for fremstilling av dinapsolin
NO20044332L (no) Forbedret fremgangsmate for fremstilling av nevirapine
NO20042202L (no) Fremgangsmate for fremstilling av asymmetriske karotenoider
IL162770A (en) Process for the preparation of 7??-methyl-estr-4-ene-3-one derivatives
FR2826004B1 (fr) Procede de preparation de derives estrogenes
NO20035138D0 (no) Fremgangsmåte til fremstilling av amorft natriumsilastatin
NO20032297D0 (no) Fremgangsmåte for fremstilling av distamycinderivater
NO20023702D0 (no) Fremgangsmåte for fremstilling av 5-arylnikotinaldehyder
NO20020328D0 (no) Fremgangsmåte for fremstilling av 4-cyano-2-aminometyltiazol

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees